Semax 10mg + Selank 10mg Blend

Product Overview

Semax + Selank Blend 10mg combines two extensively studied synthetic peptides, each developed from endogenous peptide fragments and investigated for their roles in neurological and cognitive research.

Semax, derived from a modified fragment of adrenocorticotropic hormone (ACTH), has been explored for its neurotrophic and neuroprotective properties, particularly in relation to cognitive function and neuroplasticity. Selank, a synthetic analogue of tuftsin, has been studied for its potential effects on mood regulation, stress response, and neurotransmitter modulation.

Together, this combination is of interest in research settings examining the interaction between cognitive performance, emotional regulation, and adaptive brain function.

Key Research Areas

• Cognitive performance and mental clarity (memory, focus, learning)
• Mood and stress response modulation
• Neurotransmitter activity (GABAergic, serotonergic pathways)
• Neuroplasticity and neurotrophic factor expression
• Neuroprotective mechanisms under oxidative and stress conditions

Research Insights

• Semax has been studied for its role in supporting neurotrophic factor expression (e.g., BDNF) and cognitive function
• Selank has been investigated for its influence on stress response and emotional stability through neurotransmitter modulation
• Combined research interest focuses on complementary effects between cognitive enhancement and mood regulation
• Preclinical and clinical studies suggest potential benefits in attention, adaptability, and neurological resilience markers

Safety & Tolerability (Research Context)

• Both compounds are generally well tolerated in controlled research settings
• Reported effects may include mild headache or nasal irritation (intranasal route)
• Long-term data outside regulated research environments remains limited

Disclaimer

For research purposes only. Not for human consumption.
This product is not intended to diagnose, treat, cure, or prevent any disease.
Nord Wellness makes no claims regarding therapeutic applications or outcomes.